WILX-TV |
Eczema drug effective against severe asthma
Science Daily Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable anti-inflammatory drug, was … Eczema drug may help asthma sufferers Eczema drug effective against severe asthma – Medical Xpress Eczema jab could offer new hope to millions with asthma – stopping … |
Tag Archives: Drug
A single drug may control skin cancer treatment costs
A $ 78 single course of topical fluorouracil for keratinocyte carcinoma and actinic keratosis lesions, could lead to a savings in the hundreds of dollars in follow-up costs.
Dermatology Times – Dermatology
How RA, Cancer, Hep C Drug Costs Will Change Over Next Five Years
Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control Costs
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Modern medicine – dermatology
Eczema Drug Shows Promising Phase 2 Results for Treatment of … – AJMC.com Managed Markets Network
Eczema Drug Shows Promising Phase 2 Results for Treatment of …
AJMC.com Managed Markets Network Dupilumab's effectiveness is due to the monoclonal antibody's ability to rapidly reduce inflammation. |
FDA challenges abuse-deterrent opioid drug claim
The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.
Managed Healthcare Executive – Health Management
Dermira Commits $135M for Global Rights to Roche Eczema Drug – Xconomy
Xconomy |
Dermira Commits $ 135M for Global Rights to Roche Eczema Drug
Xconomy Skin treatments developer Dermira is adding another experimental drug to its pipeline that it plans to test as a potential treatment for eczema, through a deal announced this morning with healthcare giant Roche. But in picking up the global rights to … Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab |
AADA offers patient advocacy assistance with drug costs
Expert offers insight on where to find help
Modern medicine – American Academy of Dermatology
Isotretinoin still the best drug for acne
As part of its updated guidelines for the treatment of acne published early last year, the American Academy of Dermatology included new recommendations for the use of oral isotretinoin.
Modern medicine – American Academy of Dermatology
Drug for refractory psoriatic arthritis shows promise in clinical trial
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided…
Eczema / Psoriasis News From Medical News Today